Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $464.18 | 26 | 85.9% |
| Education | $76.11 | 2 | 14.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $250.93 | 18 | $0 (2023) |
| ITI, Inc. | $125.28 | 3 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $72.20 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $27.27 | 1 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $18.04 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $17.79 | 1 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $14.97 | 1 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $13.81 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $82.13 | 2 | Teva Pharmaceuticals USA, Inc. ($54.86) |
| 2023 | $354.13 | 24 | ABBVIE INC. ($250.93) |
| 2022 | $104.03 | 2 | ITI, Inc. ($104.03) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $54.86 | General |
| Category: Central Nervous System | ||||||
| 09/05/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: PSYCHIATRY | ||||||
| 08/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $18.04 | General |
| Category: PSYCHOLOGY | ||||||
| 07/19/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: PSYCHIATRY | ||||||
| 07/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Central Nervous System | ||||||
| 06/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Neuropsychiatry | ||||||
| 06/03/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Neuroscience | ||||||
| 06/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: NEUROSCIENCE | ||||||
| 03/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: NEUROSCIENCE | ||||||
| 01/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 14 | 34 | $4,157 | $2,251 |
| 2022 | 2 | 29 | 39 | $3,744 | $2,192 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 34 | $4,157 | $2,251 | 54.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 26 | $2,154 | $1,230 | 57.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 13 | $1,590 | $962.36 | 60.5% |
About Nicole Gallimore
Nicole Gallimore is a Psychiatric/Mental Health healthcare provider based in Kent, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2022. The National Provider Identifier (NPI) number assigned to this provider is 1134876121.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nicole Gallimore has received a total of $540.29 in payments from pharmaceutical and medical device companies, with $82.13 received in 2024. These payments were reported across 28 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($464.18).
As a Medicare-enrolled provider, Gallimore has provided services to 43 Medicare beneficiaries, totaling 73 services with total Medicare billing of $4,443. Data is available for 2 years (2022–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Kent, OH
- Active Since 03/09/2022
- Last Updated 09/27/2023
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1134876121
Products in Payments
- VRAYLAR (Drug) $250.93
- CAPLYTA (Drug) $125.28
- Austedo XR (Drug) $72.20
- COBENFY (Drug) $27.27
- QELBREE (Drug) $18.04
- INVEGA SUSTENNA (Drug) $17.79
- ABILIFY ASIMTUFII (Drug) $14.97
- INGREZZA (Drug) $13.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Kent
Jenna Vo, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $14,873
Miss. Agnes Maramba, Nurse Practitioner, NURSE PRACTITIONER
Psychiatric/Mental Health — Payments: $10,236
Tina Steen, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $473.51
Tchido Yao, Np, NP
Psychiatric/Mental Health — Payments: $457.68
Allison Woerpel
Psychiatric/Mental Health — Payments: $444.99
Scott Rohrbaugh, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $252.03